Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NATEGLINIDE vs NECITUMUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NATEGLINIDE vs NECITUMUMAB: Safety Overview

Metric NATEGLINIDE NECITUMUMAB
Total FAERS Reports 183 367
Deaths Reported 19 69
Death Rate 10.4% 18.8%
Hospitalizations 51 131
Average Patient Age 64.0 yrs 65.4 yrs
% Female Patients 60.3% 20.0%
FDA Approval Date Apr 19, 2019 N/A
Manufacturer Zydus Lifesciences Limited Eli Lilly and Company
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription